Lenalidomide proved effective in multisystem Langerhans cell histiocytosis

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00059809" target="_blank" >RIV/00216224:14110/12:00059809 - isvavai.cz</a>
Alternative codes found
RIV/65269705:_____/12:#0001679 RIV/00209805:_____/12:#0000371
Result on the web
<a href="http://dx.doi.org/10.3109/0284186X.2011.631581" target="_blank" >http://dx.doi.org/10.3109/0284186X.2011.631581</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3109/0284186X.2011.631581" target="_blank" >10.3109/0284186X.2011.631581</a>

Result language
angličtina
Original language name
Lenalidomide proved effective in multisystem Langerhans cell histiocytosis
Original language description
Langerhans cell histiocytosis (LCH) is a rare idiopathic disease with diverse clinical manifestations ranging from a single osteolytic lesion to generalized disease. Various treatment regimens have been proposed for the multisystem type, however, with inconsistent outcomes. Herein we are the first to report on a therapy effect of a lenalidomide-based regimen in a patient with repeatedly relapsed aggressive form of multisystem LCH.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)